Foreign products reliance makes Korean drug firms vulnerable

Published: 2012-09-05 07:00:00

Updated: 2012-09-05 07:00:00

The government-mandated cuts in drug prices have prompted Korea’s leading drug maker to increase their dependence on foreign maker’s original drugs surge over the years.

Recent data from Yakup.com, a pharmaceutical information company, show that the local leading firm’s over-reliance on foreig...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK